Movement Alert|ILUVATAR COREX at open rise 3.46%, TianGai 300 performance and cost advantages remain in focus

Market Focus11-12

On November 12, ILUVATAR COREX rose 3.46% at open, trading at HK$74.8, with turnover of HK$5.1687 million.

The move coincided with continued market focus on the company’s recently disclosed TianGai 300 validation progress. Public information showed that under a typical PD-separated deployment, normalized single-card end-to-end throughput reached 1.05 times that of a leading international mainstream GPU, while the IXL144 supernode reduced cost per million effective tokens by about 40% versus mainstream international alternatives.

Additional disclosed operating indicators also supported attention on commercialization progress. The company previously said chip shipments in the first ten months exceeded 80,000 units, and its latest reported first-half revenue was RMB946 million, up 191.6% year over year. The combination of product validation, cost competitiveness and shipment growth has been the main publicly visible support for recent share-price activity.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment